0001493152-24-024527.txt : 20240620
0001493152-24-024527.hdr.sgml : 20240620
20240620163015
ACCESSION NUMBER: 0001493152-24-024527
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240617
FILED AS OF DATE: 20240620
DATE AS OF CHANGE: 20240620
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Silverstein Christine Berni
CENTRAL INDEX KEY: 0001772546
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-15771
FILM NUMBER: 241056715
MAIL ADDRESS:
STREET 1: C/O ABEONA THERAPEUTICS INC.
STREET 2: 1330 AVENUE OF THE AMERICAS, 33RD FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ABEONA THERAPEUTICS INC.
CENTRAL INDEX KEY: 0000318306
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 830221517
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR
CITY: CLEVELAND
STATE: OH
ZIP: 44103
BUSINESS PHONE: 646-813-4701
MAIL ADDRESS:
STREET 1: 6555 CARNEGIE AVE, 4TH FLOOR
CITY: CLEVELAND
STATE: OH
ZIP: 44103
FORMER COMPANY:
FORMER CONFORMED NAME: PLASMATECH BIOPHARMACEUTICALS INC
DATE OF NAME CHANGE: 20140922
FORMER COMPANY:
FORMER CONFORMED NAME: ACCESS PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19960209
FORMER COMPANY:
FORMER CONFORMED NAME: CHEMEX PHARMACEUTICALS INC
DATE OF NAME CHANGE: 19920703
4
1
ownership.xml
X0508
4
2024-06-17
0
0000318306
ABEONA THERAPEUTICS INC.
ABEO
0001772546
Silverstein Christine Berni
6555 CARNEGIE AVE., 4TH FLOOR
CLEVELAND
OH
44103
1
0
0
0
0
Common Stock
2024-06-18
4
S
0
25821
4.51
D
62063
D
The sale reported in this Form 4 was to cover tax obligations associated with vesting of restricted stock awards.
Weighted average price. These shares were sold in multiple transactions at prices ranging from $4.47 to $4.55 inclusive. The reporting person undertakes to provide the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above.
/s/ Christine Silverstein
2024-06-20